Anti-wrinkle injection maker Revance to go private in $924 million deal

Revance Therapeutics

12/08/2024 13:07

Aug 12 (Reuters) - Anti-wrinkle injection maker Revance
Therapeutics  RVNC.O  will be acquired by private skincare
company Crown Laboratories in a take-private deal worth $924
million, including debt, the two companies said on Monday.

 (Reporting by Leroy Leo in Bengaluru; Editing by Devika
Syamnath)
 ((Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7;))